AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

634.950

-11.153-1.73%

Number of Gainers:6

Number of Losers:15

Number of Flat:22

PE:- -

High:645.436

Open:638.323

Low:632.715

Close:646.103

Volume:82.34M

Turnover:107.75M

Market Cap:90.27B

Float Cap:87.07B

Loading ...

CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs

THOMSON REUTERS

CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027

THOMSON REUTERS

ASX Growth Companies With High Insider Ownership

Simply Wall St.

High Growth Tech Stocks In Australia Echo IQ And 2 More To Watch

Simply Wall St.

ASX Stocks Estimated Below Intrinsic Value In August 2026

Simply Wall St.

Founder Led Stocks With Long Term Alignment Investors Should Watch

Simply Wall St.

Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million

Proteomics International Laboratories - FY Revenue A$3.6 Mln

THOMSON REUTERS

Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Tissue Repair Posts FY Loss Attributable of A$5.4 Million

Tissue Repair Ltd - FY Revenues from Ordinary Activities A$3.2 Mln

THOMSON REUTERS

Tissue Repair - no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically

Simply Wall St.

Cann Group Ltd-Preliminary Final Report

THOMSON REUTERS

Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026

THOMSON REUTERS

Australia's Immutep Falls to Near 3-Week Low as 2026 Loss Widens

Orthocell Ltd - no Dividends Have Been Declared

THOMSON REUTERS

Orthocell Ltd - FY Revenue from Ordinary Activities A$11.4 Mln

THOMSON REUTERS

Immutep Says no Dividends Paid or Declared During Current FY

Cynata Therapeutics - no Dividends Declared for Fy2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK7508/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":634.9499,"timestamp":1789106399475,"preClose":646.1032,"halted":0,"volume":82340846,"delay":0,"changeRate":-0.017262,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-11.15332,"latestTime":"09-11 16:00:00 AEST","open":638.3234,"high":645.43604,"low":632.7152,"amount":107748358.18,"amplitude":0.019689,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789084800000,1789106400000]],"turnoverRate":0.00323,"increases":7,"decrements":16,"flats":20,"marketCap":90265011743.75,"floatMarketCap":87070963229.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":645.43604,"amplitude":0.019689,"preClose":646.1032,"low":632.7152,"latestPrice":634.9499,"volume":82340846,"delay":0,"open":638.3234,"prevYearClose":644.3692,"prevWeekClose":666.366,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":666.366,"twentyDayClose":541.582,"sixtyDayClose":464.274,"secType":"PLATE","market":"AU","turnoverRate":0.00323,"marketCap":90265011743.75,"floatMarketCap":87070963229.625,"timestamp":1789106399475,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":6,"down":15,"flat":22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664000707","title":"CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000707?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000088","title":"CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000088?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CSL.AU","BK7511","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837618","title":"ASX Growth Companies With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837618","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837618?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:08","pubTimestamp":1788203298,"startTime":"0","endTime":"0","summary":"As the S&P/ASX 200 reflects global market jitters with a predicted dip following Wall Street's inflation concerns, investors are keenly watching for opportunities in growth companies that demonstrate resilience and potential. In this environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those who know the company best, aligning management interests with shareholder value.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-16","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-16","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4531","VAS.AU","BK7067","FRS.AU","BK7093","VAP.AU","QFN.AU","EIQ.AU","IMLC.AU","BK7104","SLF.AU","IIGF.AU","E200.AU","PNI.AU","GEAR.AU","BK7062","BK4526","BK7017","EIGA.AU","MSB.AU","TTT.AU","OZR.AU","OZF.AU","STW.AU","PDI.AU","BK7110","AR1.AU","BK7095","QRE.AU","BEAR.AU","BK4108","GIVE.AU","SKS.AU","IOZ.AU","XKO.AU","BK4505","AWJ.AU","XAO.AU","IQ","WZR.AU","DACE.AU","IISV.AU","BK7501","XJO.AU","BK7508","SPL.AU","BBOZ.AU","ZYAU.AU","BK7023","AEM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883108","title":"High Growth Tech Stocks In Australia Echo IQ And 2 More To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883108","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883108?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:06","pubTimestamp":1788203178,"startTime":"0","endTime":"0","summary":"As the Australian market grapples with inflation concerns mirroring Wall Street's recent performance, the S&P/ASX 200 is expected to open lower despite a positive close last week. In this environment of economic uncertainty and fluctuating indices, high-growth tech stocks like Echo IQ are gaining attention for their potential to thrive through innovation and adaptability, making them compelling options for investors seeking growth opportunities in a volatile market landscape.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/high-growth-tech-stocks-in-australia-echo-iq-and-2-more-to-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/high-growth-tech-stocks-in-australia-echo-iq-and-2-more-to-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DACE.AU","VAS.AU","ZYAU.AU","BK4108","BK7067","STW.AU","BK4526","BK4552","GIVE.AU","BK7084","VAP.AU","IOZ.AU","QFN.AU","BBOZ.AU","GEAR.AU","IMLC.AU","EIGA.AU","XAO.AU","MSB.AU","BK7016","USD","BK4531","E200.AU","BK7508","CROC","SLF.AU","XKO.AU","EUFX","BEAR.AU","OZR.AU","QRE.AU","IQ","ELS.AU","OZF.AU","BK4505","BK7501","IIGF.AU","EIQ.AU","IISV.AU","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883100","title":"ASX Stocks Estimated Below Intrinsic Value In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883100","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883100?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:04","pubTimestamp":1788203070,"startTime":"0","endTime":"0","summary":"As the Australian market navigates the ripple effects of inflation concerns and potential interest rate hikes from the US, investors are keenly observing how these factors might influence local indices such as the S&P/ASX 200. Amidst this backdrop, identifying stocks that are potentially undervalued can offer opportunities for those looking to capitalize on discrepancies between market price and intrinsic value.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/media/asx-sek/seek-shares/news/asx-stocks-estimated-below-intrinsic-value-in-august-2026-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/media/asx-sek/seek-shares/news/asx-stocks-estimated-below-intrinsic-value-in-august-2026-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7128","STH.AU","CAT.AU","PNV.AU","PMDE","BK7078","BK7508","BK7094","BK7062","BMT.AU","DMP.AU","GXDW","NIC.AU","FEBU","LOV.AU","VOTE","RGLO","BK7061","NGI.AU","SEK.AU","TEA.AU","VGFPF","BK7126","NXL.AU","BK7055","BK7016","JOYT","BK7015","BK7084","SLC.AU","LNW.AU","DECU","BK7137","BK7002","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002013","title":"Founder Led Stocks With Long Term Alignment Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002013","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002013?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:22","pubTimestamp":1788189735,"startTime":"0","endTime":"0","summary":"With central banks signaling that interest rates may stay higher for longer, investors face a tougher backdrop for companies that rely on cheap capital and short term momentum. Founder led businesses often take a different path. Leaders with significant skin in the game tend to think in decades, not quarters. This article highlights 3 founder led stocks from our screener that show how this ownership mindset can shape long term opportunity.\nThe three founder led stocks in this article are only...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/founder-led-stocks-with-long-term-alignment-investors-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/founder-led-stocks-with-long-term-alignment-investors-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MQG.AU","BK7501","BK7043","BK7042","ISBC","BK7067","BK7046","BK7508","BK7511","PME.AU","MAQ.AU","BK4211","MSB.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663784060","title":"Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663784060","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663784060?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:44","pubTimestamp":1788162262,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Posts FY Loss Attributable A$8.6 MillionAug 31 -Proteomics International Laboratories LtdPIQ.AX:FY LOSS ATTRIBUTABLE A$8.6 MILLIONFY REVENUE A$3.6 MILLIONTHERE WERE NO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFurther company coverage:PIQ.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663272890","title":"Proteomics International Laboratories - FY Revenue A$3.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663272890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663272890?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:40","pubTimestamp":1788158409,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PIQ.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663027285","title":"Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663027285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663027285?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:40","pubTimestamp":1788158409,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","PIQ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022015","title":"Tissue Repair Posts FY Loss Attributable of A$5.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022015?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:13","pubTimestamp":1788156830,"startTime":"0","endTime":"0","summary":"BRIEF-Tissue Repair Posts FY Loss Attributable Of A$5.4 MillionAug 31 (Reuters)-Tissue Repair LtdTRP.AX:FY REVENUES FROM ORDINARY ACTIVITIES A$3.2 MILLIONFY LOSS ATTRIBUTABLE A$5.4 MILLIONNO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFurther company coverage:TRP.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","TRP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663220680","title":"Tissue Repair Ltd - FY Revenues from Ordinary Activities A$3.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663220680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663220680?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:12","pubTimestamp":1788156734,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRP.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663065022","title":"Tissue Repair - no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663065022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663065022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:12","pubTimestamp":1788156734,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TRP.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663607448","title":"Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically","url":"https://stock-news.laohu8.com/highlight/detail?id=2663607448","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663607448?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:37","pubTimestamp":1788151054,"startTime":"0","endTime":"0","summary":"One thing we could say about the analysts on Mesoblast Limited ( ASX:MSB ) - they aren't optimistic, having just made a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021480","title":"Cann Group Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021480?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CAN.AU","BK7502","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002145","title":"Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002145?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAN.AU","BK7502","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021517","title":"Australia's Immutep Falls to Near 3-Week Low as 2026 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021517?lang=en_us&edition=fundamental","pubTime":"2026-08-31 11:40","pubTimestamp":1788147609,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immutep falls to near 3-week low as 2026 loss widens** Shares of ImmutepIMM.AXfell as much as 4% to A$0.048, marking their lowest level since August 12** Biotechnology firm'sannual losswidens by 29.1% to A$79.3 million  from A$61.4 million in 2025** Including day's moves, stock down 88.2% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S09S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IMM.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663647029","title":"Orthocell Ltd - no Dividends Have Been Declared","url":"https://stock-news.laohu8.com/highlight/detail?id=2663647029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663647029?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:59","pubTimestamp":1788145149,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663029642","title":"Orthocell Ltd - FY Revenue from Ordinary Activities A$11.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663029642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663029642?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:59","pubTimestamp":1788145149,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663025976","title":"Immutep Says no Dividends Paid or Declared During Current FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2663025976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663025976?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:32","pubTimestamp":1788139963,"startTime":"0","endTime":"0","summary":"BRIEF-Immutep Says No Dividends Paid Or Declared During Current FYAug 31 (Reuters)-Immutep LtdIMM.AX:IMMUTEP LTD -  NO DIVIDENDS PAID OR DECLARED DURING CURRENT FYFurther company coverage:IMM.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P20Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663284430","title":"Cynata Therapeutics - no Dividends Declared for Fy2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663284430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663284430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:10","pubTimestamp":1788135014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R037:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","CYP.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":112,"code":"91000000","status":"200"}]}}